AR-positive TNBC was shown to frequently have activating mutations in the phosphatidylinositol-4, 5-biphospate 3-kinase catalytic subunit alpha (PIK3CA) or pAKT, suggesting a tumor-promoting effect, but it was sensitive to combined inhibition by PI3K and AR [89]. The gene discussed is PIK3CA; the disease is neoplasm.